期刊文献+

胆管癌组织中Wnt2b蛋白表达及其临床意义

EXPRESSION OF Wnt2b IN CHOLANGIOCARCINOMA AND ITS CLINICAL SIGNIFICANCE
下载PDF
导出
摘要 目的观察Wnt2b蛋白在胆管癌组织的表达,并探讨其在胆管癌发生发展及浸润转移过程中的临床意义。方法采用免疫组化染色方法检测60例胆管癌及30例胆管正常组织中Wnt2b蛋白的表达情况,并分析其与胆管癌临床特征的关系。结果 Wnt2b在胆管癌组织的阳性率(90.00%)明显高于正常胆管组织(3.33%),差异有显著性(χ2=38.13,P<0.01)。Wnt2b表达与胆管癌的浸润深度和淋巴结转移程度相关(Z=-3.171、-3.316,P<0.01),而与病人的年龄、性别、胆管癌发生部位及胆管癌的分化程度无关(Z=-0.048^-1.020,P>0.05)。结论 Wnt2b蛋白可能作为评估胆管癌临床分期与淋巴结转移的一种有价值的生物学标记。 Objective To observe the expression of Wnt2 bprotein and investigate its clinical significance in the development,progression,invasion and metastasis of cholangiocarcinoma(CLC). Methods Employing immunohistochemical method,the expression of Wnt2 bprotein in tissues of 60 cases of CLC and 30 normal bile duct tissues was detected,and its relationship with clinical characteristics of this malignancy was analyzed. Results The positive rate of Wnt2 bwas significantly higher in CLC than that in normal bile duct tissue(90.00% vs.3.33%,χ^2=38.13,P〈0.01).The expression of Wnt2 bwas positively correlated with depth of tumor invasion and lymph node metastasis(Z=-3.171,-3.316;P〈0.01),but it was not related to patient's age,gender,tumor location and cell differentiation(Z=-0.048--1.020,P〉0.05). Conclusion Wnt2 bis probably to be used as a useful biological marker for assessing clinical stage and lymph node metastasis of cholangiocarcinoma.
出处 《齐鲁医学杂志》 2015年第4期409-411,共3页 Medical Journal of Qilu
关键词 Wnt2b蛋白 胆管肿瘤 病理学 临床 Wnt2b protein bile duct neoplasms pathology clinical
  • 相关文献

参考文献2

二级参考文献49

  • 1Mundy GR, Chen D, Oyajobi BO. Bone remodeling. In: Favus M J, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society of Bone and Mineral Research: Washington 2003,46-58.
  • 2Bodine PV, Komm BS. Tissue culture models for studies of hormone and vitamin action in bone cells, vitam Horm 2002, 64:101-151.
  • 3Lian JB, Stein GS, Aubin JE. Bone formation: maturation and functional activities ofosteoblast lineage cells. In: Favus M J, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research: Washington 2003,13-28.
  • 4Teitelbaum SL. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
  • 5Lian JB, Stein GS. Runx2/Cbfal : a multifunctional regulator of bone formation. Curr Pharm Des 2003, 9:2677-2685.
  • 6Komori T. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 2002, 87:1-8.
  • 7Boyce BF, Xing L, Jilka RL, et al. Apoptosis in bone cells. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. Volume 1. Academic Press: San Diego 2002,151-168.
  • 8Koay MA, Brown MA. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol Med 2005, 11:129-137.
  • 9Ferrari SL, Deutsch S, Antonarakis SE. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass. Curr Opin Lipidol 2005, 16:207-214.
  • 10Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001 , 107:513-523.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部